Design and synthesis of piperazine-based matrix metalloproteinase inhibitors
about
Reagent based DOS: a "Click, Click, Cyclize" strategy to probe chemical spaceA multidisciplinary approach to probing enthalpy-entropy compensation and the interfacial mobility model.Application of a Double Aza-Michael Reaction in a 'Click, Click, Cy-Click' Strategy: From Bench to Flow.Curcumin binds in silico to anti-cancer drug target enzyme MMP-3 (human stromelysin-1) with affinity comparable to two known inhibitors of the enzyme.Matrix metalloproteinase inhibitors: do they have a place in anticancer therapy?ATP6V1H Deficiency Impairs Bone Development through Activation of MMP9 and MMP13FOXO3a promotes tumor cell invasion through the induction of matrix metalloproteinases.Recent progress in therapeutic applications of chalcones.Analysis of the application of MMP-9 inhibitor in skin melanoma: experimental study.MMPs/TIMPs imbalances in the peripheral blood and cerebrospinal fluid are associated with the pathogenesis of HIV-1-associated neurocognitive disorders.Synthesis and evaluation of cytotoxic activities of artemisinin derivatives.Photoorganocatalytic One-Pot Synthesis of Hydroxamic Acids from Aldehydes.Guanidine organocatalyst for the asymmetric Mannich-type reaction between α-isothiocyanato imide and sulfonyl imines.Matrix metalloproteinases (MMPs) mediate leukocyte recruitment during the inflammatory phase of zebrafish heart regeneration.Normal mode analysis as a prerequisite for drug design: Application to matrix metalloproteinases inhibitors
P2860
Q28751421-5A7831C7-F290-4707-85A4-F11738029408Q30503303-248AC6BD-6C23-4FF3-ACFD-761593F3FA11Q34021785-F48AE62A-7801-4779-B22E-0C52F76164D1Q34673409-CB165A51-A5B6-4C5B-8181-A7192C700E83Q34687431-AB00D4CA-45E5-4306-945B-06C200D9B2A1Q36269582-82BEF730-FE70-4D3C-9B4E-493342A3B88DQ37334058-1611C86A-41AC-474C-B2D7-0B7A93B3A957Q37895269-3D682E84-2B9D-4792-969B-9486BF39F4EDQ39154395-C2A3D94A-A042-440F-9EFC-390AD9FC21CCQ40219795-C579EC1C-8C32-4CAC-BA26-8982AB4C9E2EQ46368384-9644BE44-FFD7-48BF-85BE-154CDDD7DC30Q50230615-CC281A74-036B-484C-B954-C6EFD717D78DQ50527838-9616176F-60F6-4646-ACF9-543A4B36EC2CQ55230818-1795CAB8-6E94-4AB2-ABE0-8DAD74F515F8Q58571868-292C2FAF-2FCB-409B-A435-1FD5F2C82050
P2860
Design and synthesis of piperazine-based matrix metalloproteinase inhibitors
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Design and synthesis of piperazine-based matrix metalloproteinase inhibitors
@ast
Design and synthesis of piperazine-based matrix metalloproteinase inhibitors
@en
Design and synthesis of piperazine-based matrix metalloproteinase inhibitors
@nl
type
label
Design and synthesis of piperazine-based matrix metalloproteinase inhibitors
@ast
Design and synthesis of piperazine-based matrix metalloproteinase inhibitors
@en
Design and synthesis of piperazine-based matrix metalloproteinase inhibitors
@nl
prefLabel
Design and synthesis of piperazine-based matrix metalloproteinase inhibitors
@ast
Design and synthesis of piperazine-based matrix metalloproteinase inhibitors
@en
Design and synthesis of piperazine-based matrix metalloproteinase inhibitors
@nl
P2093
P356
P1476
Design and synthesis of piperazine-based matrix metalloproteinase inhibitors
@en
P2093
C E Snider
C M Dunaway
G E Mieling
M G Natchus
M J Janusz
P304
P356
10.1021/JM990366Q
P407
P577
2000-02-10T00:00:00Z